Streetbeat News

Earnings

XPEL

XPEL (NASDAQ:XPEL) is scheduled to release its quarterly earnings report on Thursday, 2024-02-22, with analysts estimating an EPS of $0.48. The focus will be on whether XPEL beats this estimate and provides positive guidance for the next quarter. Historical data shows mixed earnings performance and a general negative stock performance over the last year, with shares down 31.18%.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:02 pm

PBA

Pembina Pipeline (NYSE:PBA) is scheduled to release its quarterly earnings report on February 22, 2024, with analysts expecting an EPS of $0.63. Despite past earnings misses, the company's stock price has generally reacted positively to earnings announcements. Shares are currently trading at $33.65, reflecting a 1.62% increase over the last 52 weeks. Investors are particularly focused on the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:02 pm

ACCO

ACCO Brands (NYSE:ACCO) is scheduled to release its quarterly earnings report on February 22, 2024, with analysts expecting an EPS of $0.33. Investors are hopeful for a beat on this estimate and positive guidance for future growth. ACCO's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat followed by a 2.51% drop. Over the last year, ACCO shares have risen by 13.67%, indicating a generally positive outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:01 pm

AMLX

Amylyx Pharma (NASDAQ:AMLX) is scheduled to release its quarterly earnings report on February 22, 2024, with an estimated EPS of $0.23. The company's past earnings performance shows a mixed record of beating and missing EPS estimates, affecting its stock price variably. Shares have declined by 56.95% over the last 52 weeks, indicating a challenging period for long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:01 pm

BHC

Bausch Health Companies (NYSE:BHC) is anticipated to release its quarterly earnings report on February 22, 2024, with an expected EPS of $1.06. Historical data shows mixed reactions to past earnings, with the last quarter seeing a 3.13% share price increase post-earnings. Over the last year, BHC shares have declined by 10.71%, indicating potential investor concern ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:01 pm

CARS

Cars.com (NYSE:CARS) is scheduled to release its quarterly earnings report on February 22, 2024, with an expected EPS of $0.16. Analysts and investors are keen on not just the earnings beat or miss but also the company's guidance for future growth. Historical data shows mixed reactions to past earnings reports, with the last quarter missing EPS estimates but still resulting in a 7.79% share price increase the following day. Over the last year, CARS shares have declined by 7.36%, indicating potential concern among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:01 pm

LLY

Eli Lilly (NYSE:LLY) has seen significant options activity indicating mixed sentiment among big-money investors, with a bearish tilt. Benzinga's options scanner revealed 13 unusual trades, with a split of 38% bullish and 61% bearish sentiment. Notable trades include puts and calls with strike prices ranging from $610 to $900. Analysts have set varied price targets for LLY, with an average of $772. The stock is currently down by -1.57% at $743.82, potentially overbought, with earnings anticipated in 64 days.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:01 pm

ENOV

Enovis (NYSE:ENOV) is scheduled to release its quarterly earnings report on February 22, 2024, with analysts expecting an EPS of $0.74. The company's past earnings performance shows mixed results with minor share price changes following earnings announcements. Shares of Enovis have increased by 3.97% over the last 52 weeks, trading at $59.58 as of February 20. Investors are advised to pay attention to the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:01 pm

SNOW

Recent options trading trends for Snowflake (NYSE:SNOW) show a bearish stance by major investors, with 54% of trades being bearish and 45% bullish. The trading volume and open interest analysis suggest a focus on a price range between $185.0 and $222.5. The largest trades include both bullish and bearish sentiments, with significant amounts invested in calls and puts. Snowflake, a data warehousing company, has seen its stock price decrease by -3.17% to $213.11, with analysts giving mixed reviews and target prices ranging from $214 to $265. The company's next earnings are expected in 7 days.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:01 pm

MSTR

Financial analysis of MicroStrategy (NASDAQ:MSTR) options trading reveals a bearish sentiment among traders, with 64% showing bearish tendencies and 35% bullish. The trading activity focuses on a price range between $310.0 and $1000.0. The most significant options trades include both puts and calls, with puts showing a higher total trade value. MicroStrategy's current market position shows a trading volume of 161,816 and a price decrease of -3.24%, with an RSI indicating potential overbought conditions. An earnings announcement is expected in 68 days.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 3:01 pm